The Bears announced an encouraging injury update on Kyle Monangai as Chicago prepares for its Week 5 game against the Packers ...

DeMaio counters that his group backs Prop. 38 “mainly because we see the bond as different from typical government borrowing, ...

During the October 1 episode of Mad Money, Jim Cramer discussed Amgen Inc. (NASDAQ:AMGN) while reviewing the Dow Jones ...

Brain Cancer Australia chair and longtime masters triathlete Michael Besser was the oldest starter in this year's Sunshine ...

A global Phase III clinical trial of elocizumab did not meet its primary endpoint, dealing a setback to the expansion of its ...

Electoral law, final act. Today, Thursday, October 8, is the moment for the definitive approval of the 'Stabilicum' by the Chamber. The session will begin at 10:30 AM, with declarations of vote and ...

Companies are pitching full-body MRI scans directly to consumers as a way to detect cancer and other diseases early, but no major medical association—including the American Cancer Society and the ...

They seldom talk about Duchenne muscular dystrophy, the rare fatal muscle-wasting disease they live with. But lately it’s all ...

The SURVIVE trial of the targeted vaccine SurVaxM did not meet its primary OS end point due to longer-than-expected survival ...

X and Substack aren’t doing anything to stop users from harassing women they believe are connected to the rape case — and the ...

Sam Altman AI harms comments fuel criticism over risks in healthcare, roads, courts, and elections. Read what's at stake ...

Caribou Biosciences, Inc. (CRBU) is down 43.35 percent, losing $0.4920 to $0.6430 on Wednesday. Vaxcyte Prices Offerings Of Stock, Warrants, Convertible Notes To Raise Approx. $1 Bln October 07, 2026 ...